// App-Quantinova.ai

P5-02-01 : Analytical validation and prognostic potential of an automated digital scoring protocol for Ki67: An International Ki67 Working Group study

Researchers

Presenter

  • Balazs Acs

Principal Investigators

  • Kelley M. Kidwell

  • Indu Arun

  • Renaldas Augulis

  • Sunil S. Badve

  • Yalai Bai

  • Anita L. Bane

  • John M.S. Bartlett

  • Jane Bayani

  • Gilbert Bigras

  • Annika Blank

  • Signe Borgquist

  • Henk Buikema

  • Martin C. Chang

  • Robin L. Dietz

  • Andrew Dodson

  • Anna Ehinger

  • Susan Fineberg

  • Cornelia M. Focke

  • Dongxia Gao

  • Allen M. Gown

  • Carolina Gutierrez

  • Johan Hartman

  • Judith C. Hugh

  • Zuzana Kos

  • Anne-Vibeke Lnkholm

  • Arvydas Laurinavicius

  • Richard M. Levenson

  • Rustin Mahboubi-Ardakani

  • Mauro G. Mastropasqua

  • Takuya Moriya

  • Sharon Nofech-Mozes

  • C. Kent Osborne

  • Liron Pantanowitz

  • Frdrique M. Penault-Llorca

  • Tammy Piper

  • Mary Anne Quintayo

  • Tilman T. Rau

  • Stefan Reinhard

  • Stephanie Robertson

  • Takashi Sakatani

  • Roberto Salgado

  • Melanie Spears

  • Jane Starczynski

  • Tomoharu Sugie

  • Bert van der Vegt

  • Giuseppe Viale

  • Shakeel Virk

  • Lila A. Zabaglo

  • Daniel F. Hayes

  • Mitch Dowsett

  • Torsten O. Nielsen

  • David L. Rimm

Medical Centers

  • Department of Therapeutic Radiology, Yale School of Medicine, New Haven, CT

  • The University of British Columbia, Vancouver, BC, Canada

  • Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, MI

  • Tata Medical Centre, Kolkata, India

  • Vilnius University Faculty of Medicine and National Center of Pathology, Vilnius University Hospital Santaros Clinics, Vilnius, Lithuania

  • Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN

  • Juravinski Hospital and Cancer Centre, McMaster University, Hamilton, ON, CA

  • Ontario Institute for Cancer Research, Toronto, ON, Canada

  • Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, AB, Canada

  • Universität Bern Institut für Pathologie, Murtenstrasse, Switzerland

  • Lund University Hospital, Lund, Sweden

  • Universitair Medisch Centrum Groningen, Groningen, Netherlands

  • Department of Pathology and Laboratory Medicine, University of Vermont Medical Center, Burlington, VT, USA

  • Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA

  • UK NEQAS for Immunocytochemistry and In-Situ Hybridisation, London, United Kingdom

  • Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY

  • Dietrich Bonhoeffer Medical Center, Neubrandenburg, Germany

  • PhenoPath Laboratories, Seattle, WA

  • Lester and Sue Smith Breast Center, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX

  • Karolinska University Hospital, Stockholm, Sweden

  • University of Alberta, Edmonton, AB, Canada

  • University of Ottawa - Ottawa General Hospital, Ottawa, ON, Canada

  • Department of Surgical Pathology, Zealand University Hospital, Slagelse, Denmark

  • Department of Pathology and Laboratory Medicine, University of California, Davis, Sacramento, CA

  • European Institute of Oncology, Milan, Italy

  • University of Toronto - Sunnybrook Health Sciences Centre, Toronto, ON, Canada

  • Centre Jean Perrin and Université d'Auvergne, Clermont-Ferrand, France

  • Edinburgh Cancer Research UK Center, Western General Hospital, Edinburgh, United Kingdom

  • Nippon Medical Sch, Bunkyo-ku, Japan

  • Department of Pathology, GZA-ZNA, Antwerp, Belgium

  • Birmingham Heart of England, National Health Service, Birmingham, United Kingdom

  • Kansai Medical University, Hirakata, Osaka, Japan.

  • University of Milan, Milan, Italy

  • Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, Canada

  • Royal Marsden Hospital and Institute of Cancer Research, London, United Kingdom

  • University of Michigan Comprehensive Cancer Center, Ann Arbor, MI

Locations

  • United States

  • Canada

  • India

  • Lithuania

  • Switzerland

  • Sweden

  • Netherlands

  • United Kingdom

  • Germany

  • Denmark

  • Italy

  • Japan

  • France

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • Proliferation marker protein Ki-67

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved